The study of acute toxicity of the topical combination with glucosamine and ketoprofen in the form of a cream-gel

Authors

  • I. A. Zupanets National University of Pharmacy, Ukraine
  • N. V. Davishnia National University of Pharmacy, Ukraine
  • S. K. Shebeko National University of Pharmacy, Ukraine
  • M. O. Lyapunov State Scientific Institution “Institute for Single Crystals of the National Academy of sciences of Ukraine”, Ukraine

DOI:

https://doi.org/10.24959/cphj.17.1425

Keywords:

topical combination, glucosamine, ketoprofen, acute toxicity, cutaneous application, intragastric administration

Abstract

Safety of new drugs is the most important criteria for the study, and it is determined by the analysis of acute toxicity. When determining acute toxicity the adverse effects of drugs are described in their single use or multiple administrations in a short period of time.

Aim. To determine the toxicity class of a new topical combination containing 5.0 % glucosamine hydrochloride and 2.0 % in the form of a cream-gel or cutaneous application and intragastric introduction.

Materials and methods. The studies were carried out in accordance with EC Directive 86/609 EEC. The cutaneous application of the combination was in the range of doses from 43 to 22600 mg/kg. The object studied was used in the dose range from 500 to 5000 mg/kg in intragastric introduction. The behavior of animals and their survival were observed within 14 days.

Results. During the observation after cutaneous application there was no mortality, changes in the common life cycle of rats and the skin irritation. In intragastric introduction of the combination its LD50 was higher than 5000 mg/kg.

Conclusions. Therefore, the study of acute toxicity of the combination has shown the absence of mortality in rats at the maximum allowable doses for cutaneous application and intragastric introduction. This fact indicates a low toxicity of the G/K cream-gel, and it gives the possibility to refer the combination studied to the category of relatively harmless substances.

Author Biographies

I. A. Zupanets, National University of Pharmacy

Doctor of Medicine (Dr. habil.), professor, head of the Clinical Pharmacology and Clinical Pharmacy Department

N. V. Davishnia, National University of Pharmacy

Candidate of Pharmacy (Ph.D.), teaching assistant of the Clinical Pharmacology and Clinical Pharmacy Department

S. K. Shebeko, National University of Pharmacy

Candidate of Pharmacy (Ph.D.), associate professor of the Clinical Pharmacology and Clinical Pharmacy Department

M. O. Lyapunov, State Scientific Institution “Institute for Single Crystals of the National Academy of sciences of Ukraine”

Doctor of Pharmacy (Dr. habil.), professor, honored scientific consultant

References

Acute toxicity safety emporium: The MSDS HyperGlossary (2006), 11–15.

Crowl, D. A., Louvar, J. F. et al. (2011). Chemical process safety : fundamentals with applications. Third Edition, Prentice Hall, New Jersey, 254.

Guidance for industry single dose acute toxicity testing for pharmaceuticals (1996). Center for Drug Evaluation and Research (CDER), 2.

European convention for the protection of vertebrate animals used for experimental and other scientific purpose (1986).Strasbourg, 52.

Stefanov, O., Buhtіarova, T., Kovalenko, V. et al. (2009). Nastanova ST–N MOZU 42–6.0:2008. Lіkarskі zasoby. Nalezhna laboratorna praktyka. Kyiv: Morіon, 37–68.

Stefanova, O. V. (2001). Doklіnіchnі doslіdzhennia lіkarskykh zasobіv. Kyiv: Avіcenna, 528.

Yakovlieva, L. V., Tkachova, O. V., Butko, Ya. O. (2013). Eksperymentalne vyvchennia novykh preparatіv dlia mіscevoho lіkuvannia ran. Kyiv: DETCS MOZ Ukrainy, 52.

Yakovlieva, L. V., Butenko, І. H., Bezdіtko, K. P. (2008). Optimіzatsiia doklіnіchnoho vyvchennia efektyvnostі ta neshkіdlyvostі lіkarskykh zasobіv u formі mazei ta gelіv. Kyiv: Ukrmedpatentіnf., 5.

Zupanets, I.A. (1993). Kupavna, 90 .

Zupanets, K. O., Popov, S. B., Otrіshko, I.A. (2009). Klіnіchna farmatsiia – Clinical pharmacy,13 (4), 50–53.

Aiupova, R. B. (2011). Vestnik KazNMU, 3, 9–20.

Khabrieva, R. U. (2005). Rukovodstvo po eksperimentalnomu (doklinicheskomu) izucheniiu novykh farmakologicheskikh veshchestv.Moscow, 832.

Pastushenko, T. B., Marushyi, L. B., Zhukov, A. A. (1985). Gigiena i sanitaria, 6, 46–47.

Sidorov, K. K. (1973). Toksikologiia novykh promyshlennykh khimicheskikh veshhestv. Moscow: Meditsina, 3, 47.

Downloads

Published

2017-06-14

Issue

Vol. 21 No. 2 (2017)

Section

Pre-clinical studies of new drugs

License

Copyright (c) 2017 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).